The deubiquitinases USP33 and USP20 coordinate β2 adrenergic receptor recycling and resensitization

被引:141
作者
Berthouze, Magali [1 ]
Venkataramanan, Vidya [1 ]
Li, Yi [1 ]
Shenoy, Sudha K. [1 ,2 ]
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA
关键词
arrestin; cAMP; GPCR; lysosomes; recycling; PROTEIN-COUPLED RECEPTORS; LINDAU TUMOR-SUPPRESSOR; EPIDERMAL-GROWTH-FACTOR; BETA(2)-ADRENERGIC RECEPTOR; 7-TRANSMEMBRANE RECEPTORS; MEMBRANE TRAFFICKING; DOWN-REGULATION; UBIQUITINATION; ARRESTIN; DEGRADATION;
D O I
10.1038/emboj.2009.128
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Agonist-induced ubiquitination of the beta(2) adrenergic receptor (beta(2)AR) functions as an important post-translational modification to sort internalized receptors to the lysosomes for degradation. We now show that this ubiquitination is reversed by two deubiquitinating enzymes, ubiquitin-specific proteases (USPs) 20 and 33, thus, inhibiting lysosomal trafficking when concomitantly promoting receptor recycling from the late-endosomal compartments as well as resensitization of recycled receptors at the cell surface. Dissociation of constitutively bound endogenously expressed USPs 20 and 33 from the beta(2)AR immediately after agonist stimulation and reassociation on prolonged agonist treatment allows receptors to first become ubiquitinated and then deubiquitinated, thus, providing a 'trip switch' between degradative and recycling pathways at the late-endosomal compartments. Thus, USPs 20 and 33 serve as novel regulators that dictate both post-endocytic sorting as well as the intensity and extent of beta(2)AR signalling from the cell surface. The EMBO Journal (2009) 28, 1684-1696. doi:10.1038/emboj.2009.128; Published online 7 May 2009
引用
收藏
页码:1684 / 1696
页数:13
相关论文
共 37 条
[1]   Degradation of endocytosed epidermal growth factor and virally ubiquitinated major histocompatibility complex class I is independent of mammalian ESCRTII [J].
Bowers, K ;
Piper, SC ;
Edeling, MA ;
Gray, SR ;
Owen, DJ ;
Lehner, PJ ;
Luzio, JP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (08) :5094-5105
[2]   Endocytosis:: the DUB version [J].
Clague, Michael J. ;
Urbe, Sylvie .
TRENDS IN CELL BIOLOGY, 2006, 16 (11) :551-559
[3]   Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation [J].
Curcio-Morelli, C ;
Zavacki, AM ;
Christofollete, M ;
Gereben, B ;
de Freitas, BCG ;
Harney, JW ;
Li, ZB ;
Wu, G ;
Bianco, AC .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (02) :189-196
[4]   β-arrestins and cell signaling [J].
DeWire, Scott M. ;
Ahn, Seungkirl ;
Lefkowitz, Robert J. ;
Shenoy, Sudha K. .
ANNUAL REVIEW OF PHYSIOLOGY, 2007, 69 :483-510
[5]   Trafficking of G protein-coupled receptors [J].
Drake, Matthew T. ;
Shenoy, Sudha K. ;
Lefkowitz, Robert J. .
CIRCULATION RESEARCH, 2006, 99 (06) :570-582
[6]  
Ferguson SSG, 2001, PHARMACOL REV, V53, P1
[7]   Role of clathrin-mediated endocytosis in agonist-induced down-regulation of the β2-adrenergic receptor [J].
Gagnon, AW ;
Kallal, L ;
Benovic, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (12) :6976-6981
[8]   The evasive nature of drug efficacy:: implications for drug discovery [J].
Galandrin, Segolene ;
Oligny-Longpre, Genevieve ;
Bouvier, Michel .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (08) :423-430
[9]   Regulation of G protein-coupled receptor signaling by scaffold proteins [J].
Hall, RA ;
Lefkowitz, RJ .
CIRCULATION RESEARCH, 2002, 91 (08) :672-680
[10]  
Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830